New insider activity at AbSci ( (ABSI) ) has taken place on September 24, 2025.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
In a recent series of transactions involving AbSci stock, SVP and CAO Todd Bedrick made a significant purchase of 10,000 shares, valued at $27,000. Additionally, Director Pangalos Menelas N acquired a substantial 95,785 shares, with a total worth of $254,788. These strategic investments by key company insiders highlight their confidence in AbSci’s future prospects.
Recent Updates on ABSI stock
Absci Corp. recently held its earnings call, revealing a mixed outlook. The company reported progress in clinical trials and strategic partnerships, crucial for strengthening its financial position and drug development capabilities. However, increased R&D expenses and low revenue figures were noted as challenges. Key developments include the initiation of Phase I clinical trials for ABS-101, progress on the ABS-201 program, a $20 million strategic investment by AMD, and a successful capital raise of approximately $64 million. The partnership with Almirall expanded, with potential milestone payments of around $650 million. Despite decreased cash and investments, Absci’s forward guidance emphasizes out-licensing and partnerships, anticipating a new drug creation partnership with a large pharma company. These factors contribute to a balanced sentiment, positioning Absci for future growth despite financial pressures.
Spark’s Take on ABSI Stock
According to Spark, TipRanks’ AI Analyst, ABSI is a Neutral.
AbSci’s overall stock score reflects significant financial and operational challenges, with negative profitability and cash flow metrics weighing heavily. Technical indicators suggest a bearish trend, and valuation metrics highlight ongoing losses. Despite these challenges, strategic partnerships and clinical trial progress offer potential long-term growth opportunities.
To see Spark’s full report on ABSI stock, click here.
More about AbSci
YTD Price Performance: -4.06%
Average Trading Volume: 5,173,195
Technical Sentiment Signal: Sell
Current Market Cap: $402.2M